SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-20-010354
Filing Date
2020-04-29
Accepted
2020-04-29 08:58:59
Documents
2
Group Members
ADI WOLFCLOVER WOLF LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea121088-13gclover_pluristem.htm SC 13G 104126
2 AGREEMENT OF JOINT FILING ea121088ex99-1_pluristem.htm EX-99.1 5456
  Complete submission text file 0001213900-20-010354.txt   111313
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Subject) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-78785 | Film No.: 20827629
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BOODENHIMER 24 TEL AVIV L3 6200838
Business Address BOODENHIMER 24 TEL AVIV L3 6200838 00972546444183
CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP (Filed by) CIK: 0001810117 (see all company filings)

IRS No.: 000000000
Type: SC 13G